Predominant expression of alternative PAX3 and PAX7 forms in myogenic and neural tumor cell lines
- PMID: 10554014
Predominant expression of alternative PAX3 and PAX7 forms in myogenic and neural tumor cell lines
Abstract
PAX3 and PAX7 are closely related paired box family members expressed during early neural and myogenic development. Assay of PAX3 and PAX7 mRNA expression in embryonal rhabdomyosarcoma, neuroblastoma, Ewing's sarcoma, and melanoma cell lines revealed tumor-specific expression patterns similar to the corresponding embryonic lineages. Although the mammalian PAX3 and PAX7 genes were reported to contain eight exons, we found that the predominant PAX3 and PAX7 transcripts in these tumor lines contain previously uncharacterized ninth exons. These splicing events alter the COOH-terminal coding regions of the encoded products but do not alter the transcriptional activity as assayed using a reporter gene with a model PAX3/PAX7 binding site. However, the findings of nearly identical COOH-terminal regions within the corresponding genes of the avian and fish genomes suggest conserved functional roles for these regions that require further investigation.
Similar articles
-
Co-expression of alternatively spliced forms of PAX3, PAX7, PAX3-FKHR and PAX7-FKHR with distinct DNA binding and transactivation properties in rhabdomyosarcoma.Int J Cancer. 2005 May 20;115(1):85-92. doi: 10.1002/ijc.20844. Int J Cancer. 2005. PMID: 15688409
-
Aberrant PAX3 and PAX7 expression. A link to the metastatic potential of embryonal rhabdomyosarcoma and cutaneous malignant melanoma?Histol Histopathol. 2003 Apr;18(2):529-39. doi: 10.14670/HH-18.529. Histol Histopathol. 2003. PMID: 12647804 Review.
-
PAX3 and PAX7 exhibit conserved cis-acting transcription repression domains and utilize a common gain of function mechanism in alveolar rhabdomyosarcoma.Oncogene. 1999 Jul 29;18(30):4348-56. doi: 10.1038/sj.onc.1202812. Oncogene. 1999. PMID: 10439042
-
Detection of PAX3-FKHR and PAX7-FKHR fusion transcripts in rhabdomyosarcoma by reverse transcriptase-polymerase chain reaction using paraffin-embedded tissue.Zhonghua Yi Xue Za Zhi (Taipei). 1999 Feb;62(2):86-91. Zhonghua Yi Xue Za Zhi (Taipei). 1999. PMID: 10063718
-
The role of Pax3 and Pax7 in development and cancer.Crit Rev Oncog. 1998;9(2):141-9. doi: 10.1615/critrevoncog.v9.i2.40. Crit Rev Oncog. 1998. PMID: 9973247 Review.
Cited by
-
PAX3 is a biomarker and prognostic factor in melanoma: Database mining.Oncol Lett. 2019 Jun;17(6):4985-4993. doi: 10.3892/ol.2019.10155. Epub 2019 Mar 18. Oncol Lett. 2019. PMID: 31186709 Free PMC article.
-
Phosphorylation of BRN2 modulates its interaction with the Pax3 promoter to control melanocyte migration and proliferation.Mol Cell Biol. 2012 Apr;32(7):1237-47. doi: 10.1128/MCB.06257-11. Epub 2012 Jan 30. Mol Cell Biol. 2012. PMID: 22290434 Free PMC article.
-
Alternate PAX3 and PAX7 C-terminal isoforms in myogenic differentiation and sarcomagenesis.Clin Transl Oncol. 2011 Mar;13(3):194-203. doi: 10.1007/s12094-011-0640-y. Clin Transl Oncol. 2011. PMID: 21421465
-
Pigmentation PAX-ways: the role of Pax3 in melanogenesis, melanocyte stem cell maintenance, and disease.Pigment Cell Melanoma Res. 2008 Dec;21(6):627-45. doi: 10.1111/j.1755-148X.2008.00514.x. Pigment Cell Melanoma Res. 2008. PMID: 18983540 Free PMC article. Review.
-
Downregulation of α-Melanocyte-Stimulating Hormone-Induced Activation of the Pax3-MITF-Tyrosinase Axis by Sorghum Ethanolic Extract in B16F10 Melanoma Cells.Int J Mol Sci. 2018 Jun 1;19(6):1640. doi: 10.3390/ijms19061640. Int J Mol Sci. 2018. PMID: 29865165 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Medical